Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Total Non-Current Liabilities came in at -$89.3 million in Q2 2026, down 0.98% year-over-year from -$90.1 million in Q2 2025, and up 0.72% quarter-over-quarter from -$89.9 million in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Total Non-Current Liabilities for 7 consecutive years, with -$89.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 0.98% year-over-year to -$89.3 million in Q2 2026; TTM through Jun 2026 was -$89.3 million, a 0.98% decrease from a year earlier, with the FY2025 full-year figure at -$87.8 million, down 118.38% from the prior year.
- Total Non-Current Liabilities was -$89.3 million for Q2 2026 at Stevanato Group S.p.A, up from -$89.9 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $477.6 million in Q4 2024 and troughed at -$91.2 million in Q3 2025.
- A 5-year average of -$2.3 million and a median of -$78.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities soared 90.99% in 2023 and sank 118.38% in 2025, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $205.4 million in 2022, then soared by 90.99% to $392.2 million in 2023, then gained by 21.77% to $477.6 million in 2024, then slumped by 118.38% to -$87.8 million in 2025, then declined by 1.71% to -$89.3 million in 2026.
- The last three Total Non-Current Liabilities figures came in at -$89.3 million (Q2 2026), -$89.9 million (Q1 2026), and -$87.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 23.92 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 17.56 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 996.30 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 12.41 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -89.27 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 75.19 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 13.70 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 4.54 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 333,758.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -89.27 Mn |
| Mar 31, 2026 | -89.91 Mn |
| Dec 31, 2025 | -87.77 Mn |
| Sep 30, 2025 | -91.19 Mn |
| Jun 30, 2025 | -88.41 Mn |
| Mar 31, 2025 | -86.99 Mn |
| Dec 31, 2024 | 477.62 Mn |
| Sep 30, 2024 | -81.38 Mn |
| Jun 30, 2024 | -78.83 Mn |
| Mar 31, 2024 | -78.65 Mn |
| Dec 31, 2023 | 392.23 Mn |
| Sep 30, 2023 | -80.45 Mn |
| Jun 30, 2023 | -74.05 Mn |
| Mar 31, 2023 | -57.32 Mn |
| Dec 31, 2022 | 205.36 Mn |
| Sep 30, 2022 | -51.02 Mn |
| Jun 30, 2022 | -39.27 Mn |
| Mar 31, 2022 | -41.41 Mn |
| Dec 31, 2021 | 272.91 Mn |
| Sep 30, 2021 | 315.78 Mn |